Brief: Inhibikase Therapeutics Says On October 9 Co Entered Into Securities Purchase Agreement In Connection With A Private Placement
10/10/2024 22:56
Oct 10 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* INHIBIKASE THERAPEUTICS INC: ON OCTOBER 9 CO ENTERED INTO
SECURITIES PURCHASE AGREEMENT IN CONNECTION WITH A PRIVATE
PLACEMENT
* INHIBIKASE THERAPEUTICS INC: UNDER THE AGREEMENT, CO
AGREED TO
SELL 58.3 MILLION SHARES OF COS COMMON STOCK
Source text for Eikon: ID:n0001193125-24-236039
Further company coverage: IKT.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share